13 Recruiting Studies Using Belimumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Belimumab
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
📍 GSK Investigational Site — Cincinnati, Ohio
Systemic Lupus Erythematosus
View Study & Checklist ➔Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
📍 Hospital for Special Surgery — New York, New York
Systemic Sclerosis
View Study & Checklist ➔Trial of Belimumab in Early Lupus
📍 Feinstein Institute — Manhasset, New York
Lupus Erythematosus, Systemic
View Study & Checklist ➔Belimumab in Autoimmune Hepatitis
📍 University of Calgary — Calgary, Alberta
Autoimmune Hepatitis
View Study & Checklist ➔Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Idiopathic CD4 Lymphopenia
View Study & Checklist ➔A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
📍 GSK Investigational Site — Phoenix, Arizona
Systemic Sclerosis Associated Interstitial Lung Disease
View Study & Checklist ➔A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
📍 GSK Investigational Site — Los Angeles, California
Lung Diseases, Interstitial
View Study & Checklist ➔A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
📍 GSK Investigational Site — Philadelphia, Pennsylvania
Connective Tissue Diseases
View Study & Checklist ➔PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
📍 Purushotham & Akther Kotha MD, Inc. — La Mesa, California
Lupus Nephritis
View Study & Checklist ➔Belimumab With Rituximab for Primary Membranous Nephropathy
📍 University of Alabama at Birmingham School of Medicine: Division of Nephrology — Birmingham, Alabama
Membranous Nephropathy
View Study & Checklist ➔A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
📍 GSK Investigational Site — Scottsdale, Arizona
Systemic Lupus Erythematosus
View Study & Checklist ➔A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
📍 GSK Investigational Site — Anniston, Alabama
Systemic Lupus Erythematosus
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔